Table 1. Comparison of vertigo control and hearing loss in studies using gentamicin at frequent intervals.
| Study | Date | Patients | Injection or titration | Hearing loss | Vertigo control |
|---|---|---|---|---|---|
| Möller et al 2 | 1988 | 15 | 3–11 days injection | 5 (33.4%) | 14 (93.4%) |
| Laitakari 3 | 1990 | 20 | 3 days injection | 9 (45%) | 18 (90%) |
| Parnes et al 4 | 1993 | 12 | 3 times titration daily for 4 days | 5 (41.7%) | 12 (100%) |
| Murofushi et al 5 | 1997 | 18 | 3–5 days injection | 6 (30%) | 14 (77.8%) |
| Corsten et al 6 | 1997 | 21 | 3 times titration daily for 4 days | 12 (57%) | 17 (80.9%) |
| Rauch et al 7 | 1997 | 21 | Twice daily–twice weekly | 5 (24%) | 20 (95%) |
| Kaplan et al 8 | 2002 | 90 | 3 times titration daily for 4 days | 22 (25.6%) | 84 (93.4%) |